Ge Healthcare Technologies Inc Revenue Growth Rates (GEHC), Current and Historic Growth - CSIMarket
CSIMarket Company Name, Ticker, Customers, else..
 


• Revenue Y/Y
• Op. Income Y/Y
• Cop. Income Y/Y
• Net Income Y/Y
• Eps Cop. Y/Y
• Eps Net Y/Y
• Free Cash Flow Y/Y
• Cash Flow Y/Y
• Capex Y/Y
• Sales Y/Y Annual
Ge Healthcare Technologies Inc   (NASDAQ: GEHC)
    Sector • Healthcare    Industry • Medical Laboratories
   Industry • Medical Laboratories
   Sector • Healthcare
 

GEHC's Revenue Growth by Quarter and Year

Ge Healthcare Technologies Inc 's Revenue results by quarter and year



Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

API endpoints for this dataset

https://api.csimarket.com/api/v1/companies/GEHC/growth
https://api.csimarket.com/api/v1/companies/GEHC/fundamentals
https://api.csimarket.com/api/v1/companies/GEHC/fundamentals?mode=as_of&as_of=YYYY-MM-DD
Programmatic access for models, analytics, and integration workflows.
Explore the Financial Data API
Financial API Point-in-Time Financial Fundamentals API API Server API Docs API Discovery
Connect Your AI Assistant
How to Connect Your AI Assistant to CSIMarket MCP MCP Server
Access this full dataset via API
Free sample Full docs All endpoints
GEHC Revenue (in millions $) FY 2026 FY 2025 FY 2024 FY 2023
4th Quarter December -
3rd Quarter September 5,513.00
2nd Quarter June 5,295.00
1st Quarter March 4,260.00
FY 15,068.00





GEHC Revenue third quarter 2026 Y/Y Growth Comment
Ge Healthcare Technologies Inc showed record Revenue growth in the third quarter 2026 with 29.41% from the third quarter 2026 2025, to $ 5,513.00 millions.

Looking into third quarter 2026 results within Medical Laboratories industry 7 other companies have achieved higher Revenue growth. While Ge Healthcare Technologies Inc ' s Revenue rise of 29.41% ranks overall at the positon no. 770 in the third quarter 2026.


GEHC Revenue ( Y/Y Growth %) 2026
 FY 2025 FY 2024 FY 2023
4th Quarter December -
3rd Quarter September 29.41 %
2nd Quarter June 27.74 %
1st Quarter March 7.17 %
FY   -

Financial Statements
Ge Healthcare Technologies Inc 's third quarter 2026 Revenue $ 5,513.00 millions GEHC's Income Statement
Ge Healthcare Technologies Inc 's third quarter 2025 Revenue $ 4,260.00 millions Quarterly GEHC's Income Statement


GEHC Revenue (Quarter on Quarter Growth %)

 2026
 FY 2025 FY 2024 FY 2023
4th Quarter December -
3rd Quarter September 4.12 %
2nd Quarter June 24.3 %
1st Quarter March -11.43 %
FY (Year on Year)   -


Back to GEHC Growth rate Comparisons >> Back to GEHC Growth rate Comparisons >>


Revenue third quarter 2026 Y/Y Growth Company Ranking
Within: No.
Medical Laboratories Industry #8
Healthcare Sector #166
Overall #770

Revenue Y/Y Growth Statistics
High Average Low
29.41 % 2.72 % -12.35 %
 
Revenue third quarter 2026 Y/Y Growth Company Ranking
Within: No.
Medical Laboratories Industry #8
Healthcare Sector #166
Overall #770
Revenue Y/Y Growth Statistics
High Average Low
29.41 % 2.72 % -12.35 %
 

Revenue by Quarter for the Fiscal Years 2023, 2024, 2025, 2026

Ge Healthcare Technologies Inc 's Q/Q Revenue Growth


Revenue Q/Q Growth Statistics
High Average Low
24.3 % 1.87 % -20.45 %
(Jun 30 2026)  


GEHC's III. Quarter Q/Q Revenue Comment
Ge Healthcare Technologies Inc achieved in the III. Quarter 2026 above company average sequential Revenue growth of 4.12%, to $ 5,513.00 millions, from $5,295.00 millions in the second quarter.

Within Medical Laboratories industry 11 other companies have achieved higher Revenue quarter on quarter growth. While Ge Healthcare Technologies Inc 's Revenue growth quarter on quarter, overall rank is 1254.


Revenue Q/Q Growth Company Ranking
Within: No.
Medical Laboratories Industry #12
Healthcare Sector #181
Overall #1254
Revenue Q/Q Growth Company Ranking
Within: No.
Medical Laboratories Industry #12
Healthcare Sector #181
Overall #1254
Revenue Q/Q Growth Statistics
High Average Low
24.3 % 1.87 % -20.45 %
(Jun 30 2026)  


GEHC's III. Quarter Q/Q Revenue Comment
Ge Healthcare Technologies Inc achieved in the III. Quarter 2026 above company average sequential Revenue growth of 4.12%, to $ 5,513.00 millions, from $5,295.00 millions in the second quarter.

Within Medical Laboratories industry 11 other companies have achieved higher Revenue quarter on quarter growth. While Ge Healthcare Technologies Inc 's Revenue growth quarter on quarter, overall rank is 1254.


Ge Healthcare Technologies Inc 's 12 Months Revenue Growth Year on Year


Revenue TTM Growth

12 Months Ending
(Sep 30 2026)		 12 Months Ending (Jun 30 2026) 12 Months Ending (Mar 31 2026) 12 Months Ending (Dec 31 2025) 12 Months Ending (Sep 30 2025)
Cumulative Revenue 12 Months Ending $ 19,878.00
Y / Y Revenue Growth (TTM) 17.75 %
Year on Year Revenue Growth Overall Ranking # 2060
Seqeuential Revenue Change (TTM) 6.73 %
Seq. Revenue Growth (TTM) Overall Ranking # 2060


Cumulative Revenue growth Comment
With 17.75% annual Revenue growth, Ge Healthcare Technologies Inc would report a record annual Revenue increase if the fiscal year would end on Sep 30 2026.

In the Healthcare sector 333 other companies have achieved higher trailing twelve month Revenue growth. While Total ranking has impoved so far to 2060, from total ranking in previous quarter at 2444.

Revenue TTM Y/Y Growth Company Ranking
Within: No.
Medical Laboratories Industry # 23
Healthcare Sector # 334
Overall # 2330

Revenue TTM Y/Y Growth Statistics
High Average Low
17.75 %
 1.44 %
-10.65 %
(Sep 30 2026)  


Revenue TTM Q/Q Growth Company Ranking
Within: No.
Industry # 23
Sector # 364
S&P 500 # 2536
Cumulative Revenue growth Comment
With 17.75% annual Revenue growth, Ge Healthcare Technologies Inc would report a record annual Revenue increase if the fiscal year would end on Sep 30 2026.

In the Healthcare sector 333 other companies have achieved higher trailing twelve month Revenue growth. While Total ranking has impoved so far to 2060, from total ranking in previous quarter at 2444.


Revenue TTM Y/Y Growth Company Ranking
Within: No.
Medical Laboratories Industry # 23
Healthcare Sector # 334
Overall # 2330

Revenue TTM Y/Y Growth Statistics
High Average Low
17.75 %
1.44 %
-10.65 %
(Sep 30 2026)  


Revenue TTM Q/Q Growth Company Ranking
Within: No.
Industry # 23
Sector # 364
S&P 500 # 2536




Other Revenue Growth
Medical Laboratories Industry Revenue Growth Trends and Statistics
Healthcare Sector Revenue Growth Statistics
Revenue Growth Trends for overall market
GEHC's Revenue Growth Ratio versus Medical Laboratories Industry, Healthcare Sector and total Market
Highest Ranking Revenue Growth
Lowest Ranking Revenue Growth




Companies with similar Revenue increase for the quarter ending Sep 30 2026 within Healthcare SectorY/Y Change %Revenue for the quarter ending Sep 30 2026
Innovative Eyewear Inc 51.12%$ 51.123 millions
Strata Critical Medical Inc 50.27%$ 50.272 millions
Madrigal Pharmaceuticals Inc 50.13%$ 50.127 millions
Immucell Corporation49.91%$ 49.912 millions
Hims and Hers Health Inc 48.88%$ 48.877 millions
Maxcyte inc 48.66%$ 48.660 millions
Billiontoone Inc 47.43%$ 47.431 millions
Arcutis Biotherapeutics Inc 45.05%$ 45.052 millions
Zevra Therapeutics Inc 44.86%$ 44.864 millions
Xeris Biopharma Holdings Inc 44.16%$ 44.158 millions
Nephros Inc 43.60%$ 43.602 millions
Cardiff Oncology Inc 42.50%$ 42.500 millions
Neurocrine Biosciences Inc 41.24%$ 41.238 millions
Transmedics Group Inc 41.15%$ 41.149 millions
Uniqure N v 40.39%$ 40.394 millions
Harrow Inc 40.00%$ 40.001 millions
Mirum Pharmaceuticals Inc 39.63%$ 39.629 millions
Caredx Inc 39.29%$ 39.285 millions
Halozyme Therapeutics Inc 39.15%$ 39.154 millions
Eli Lilly And Company38.61%$ 38.613 millions
Myomo Inc 37.42%$ 37.416 millions
Editas Medicine Inc 37.41%$ 37.412 millions
Beyond Air Inc 36.55%$ 36.545 millions
Clearpoint Neuro Inc 36.27%$ 36.271 millions
Regeneron Pharmaceuticals Inc 36.27%$ 36.265 millions
Travere Therapeutics Inc 36.22%$ 36.215 millions
Omada Health Inc 36.13%$ 36.133 millions
Guardant Health Inc 36.12%$ 36.116 millions
Natera Inc 34.08%$ 34.077 millions
Establishment Labs Holdings Inc 34.08%$ 34.075 millions


About Ge Healthcare Technologies Inc Revenue Growth Rates (GEHC), Current and Historic Growth - CSIMarket Analysis

How we calculate this

This page is based on issuer-reported fundamentals and CSIMarket’s U.S. equities database (20+ years). Growth is computed using year-over-year (Y/Y), sequential, and trailing-twelve-month (TTM) methods.

What’s included here

Company: Ge Healthcare Technologies Inc (CIK 1932393).

Source & verification

Last updated

  • Page updated:
  • Data lineage: SEC filings → XBRL parse → normalization CSIMarket.com Database → growth calculations.
  • Accession: 0001932393-26-000059
  • Figures are derived from filed reports and may be restated; numbers are subject to revision.

Sources: Ge Healthcare Technologies Inc’s SEC filings (XBRL/Inline XBRL) and CSIMarket.com’s normalization & QA processes.



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.